Findings from this randomized, double-blind clinical trial suggest that there are associations between NOS3 variants and CHD and heart failure, as well as pharmacogenetic associations for the −690 C>T variant of NOS3 with stroke, and for the glu298asp G>T variant with all-cause mortality when comparing amlodipine with lisinopril. The gene discussed is NOS3; the disease is heart failure.